Three common antihistamine medications have been found in preliminary tests to inhibit infection of cells by the coronavirus that causes COVID-19, University of Florida Health researchers have found.
Armed with a $1 million award from the National Institutes of Health, universities and health care entities throughout the state of Florida are collaborating to provide outreach and engagement to ethnic and racial minority communities disproportionately affected by the COVID-19 pandemic.
The CTSI is pleased to announce Kristianna Fredenburg, M.D.,Ph.D., an assistant professor in the department of pathology, immunology, and laboratory medicine in the UF College of Medicine, as the new director of the CTSI Biorepository. Fredenburg replaces Michael Clare-Salzler, M.D., a professor and chair of the…
Linda B. Cottler, Ph.D., MPH, FACE, CTSI community engagement program director, is a principal investigator on the grant with researchers from the University of Michigan and the University of California-Davis.
This series will feature UF investigators funded by the Rapid-Response Translational Research Projects to Address COVID-19 Pandemic pilot program. The goal of this program is to stimulate cross-disciplinary knowledge and research.
For UF researchers, pausing and resuming work brought challenges and sparked creativity as hundreds of teams across campus took aim at COVID-19.
UF researchers aim to identify drugs that could prevent and/or treat infection with COVID-19 by interfering with the way it binds to its cellular receptor, facilitating transmission to the respiratory system.
UF Health leaders have taken steps to speed novel coronavirus research, recognizing the urgent need to provide answers and options to the communities they serve. There are two key components of this effort: IRB retooled its approval process for coronavirus trials, and the UF Clinical and Translational Science Institute, or CTSI, set up a $2 million pilot research fund for scientists with translational projects that can be rapidly mobilized.
See a list of COVID-19 updates and funding announcements relevant to clinical and translational science at UF.
A leading expert in the search for ways to treat aggressive adult and pediatric brain tumors, Duane Mitchell, M.D., Ph.D., was named director of the UF CTSI, assistant vice president for research, and associate dean for translational science and clinical research.
